"臺北市立萬芳醫院委託-財團法人臺北醫學大學辦理"

During the past decade, Wan-Fang Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wan-Fang Hospital" #1 sponsor was "Taipei Medical University WanFang Hospital" with 6 trials, followed by "Academia Sinica, Taiwan" with 1 trials sponsored, "AndroScience Corp" with 1 trials sponsored, "BioLite, Inc." with 1 trials sponsored and "Dizal Pharmaceuticals" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wan-Fang Hospital" #1 collaborator was "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Centre Hospitalier Régional Universitaire de Nancy" with 1 trials as a collaborator, "Chang Gung Memorial Hospital" with 1 trials as a collaborator and "China Medical University Hospital" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Wan-Fang Hospital" are "Stroke" (2 trials), "Acne" (1 trials), "Cardiovascular Disease" (1 trials), "Cesarian Scar" (1 trials) and "Chronic Kidney Diseases" (1 trials). Many other conditions were trialed in "Wan-Fang Hospital" in a lesser frequency.

Most popular intervention types in "Wan-Fang Hospital" are "Drug" (6 trials), "Other" (6 trials), "Behavioral" (2 trials), "Device" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "placebo" (2 trials), "ASC-J9" (1 trials), "Acetylsalicylic acid" (1 trials) and "Buffalo horn technique" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wan-Fang Hospital" are 12 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Wan-Fang Hospital". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Wan-Fang Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wan-Fang Hospital, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".